Antibody-drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (I)

被引：4
|
作者：
Wang, Peng-Hui [1 ,2 ,3 ,4 ]
Liu, Chia-Hao [1 ,2 ,3 ]
Yang, Szu-Ting [4 ]
机构：
[1] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, 201 Sect 2,Shih Pai Rd, Taipei 11217, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[3] Female Canc Fdn, Taipei, Taiwan
[4] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan
来源：
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY | 2024年 / 63卷 / 06期
关键词：
FRONT-LINE CHEMOIMMUNOTHERAPY; PART II; RECURRENT;
D O I：
10.1016/j.tjog.2024.09.005
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：817 / 819
页数：3
相关论文
共 50 条
  • [31] Sulfatase-cleavable linkers for antibody-drug conjugates (ADCs)
    Bargh, Jonathan
    Walsh, Stephen
    Isidro-Llobet, Albert
    Spring, David
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [32] Advances with antibody-drug conjugates in breast cancer treatment
    Subhan, Md Abdus
    Torchilin, Vladimir P.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2021, 169 : 241 - 255
  • [33] Antibody-drug conjugates—an emerging class of cancer treatment
    Nikolaos Diamantis
    Udai Banerji
    British Journal of Cancer, 2016, 114 : 362 - 367
  • [34] Antibody-drug conjugates: an emerging modality for the treatment of cancer
    Leal, Mauricio
    Sapra, Puja
    Hurvitz, Sara A.
    Senter, Peter
    Wahl, Alan
    Schutten, Melissa
    Shah, Dhaval K.
    Haddish-Berhane, Nahor
    Kabbarah, Omar
    ANNALS REPORTS, AUGUST 2014, 2014, 1321 : 41 - 54
  • [35] Activity of antibody-drug conjugates (ADCs) with radiation in preclinical bladder cancer models.
    D'Andrea, Vincent
    Zhou, Yuzhen
    Shanmugam, Surish
    Chroneos, Rea
    Stelter, Isabella
    Hanlon, Timothy
    Bekele, Raie
    Anderson, William
    Carvalho, Filipe L. F.
    Bellmunt, Joaquim
    Mouw, Kent William
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 664 - 664
  • [36] Gastrointestinal toxicity of antibody-drug conjugates (ADCs) in metastatic breast cancer: A pooled analysis
    di Mauro, Pierluigi
    Pedersini, Rebecca
    Petrelli, Fausto
    Ghidini, Antonio
    Amoroso, Vito
    Laini, Lara
    Parati, Maria Chiara
    Bossi, Paolo
    Berruti, Alfredo
    CANCER RESEARCH, 2022, 82 (04)
  • [37] Efficacy and toxicity of antibody-drug conjugates (ADCs) in the treatment of metastatic urothelial cancer (mUC): A systematic review.
    De Padua, Tiago Costa
    Malena, Greta
    Moschini, Marco
    Martini, Alberto
    Marandino, Laura
    Raggi, Daniele
    Briganti, Alberto
    Montorsi, Francesco
    Necchi, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16536 - E16536
  • [38] Antibody-Drug Conjugates in Prostate Cancer
    Danila, Daniel C.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (08) : 447 - 449
  • [39] Antibody-Drug Conjugates for Breast Cancer
    Marme, Frederik
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (1-2) : 26 - 36
  • [40] Antibody-drug conjugates in breast cancer
    Zhu, Yinxing
    Song, Yaqi
    Zhou, Xilei
    Zhang, Wenwen
    Luo, Honglei
    CARCINOGENESIS, 2025, 46 (01)
12345